Star Equity Holdings Inc
NASDAQ:STRR
Star Equity Holdings Inc
Revenue
Star Equity Holdings Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Star Equity Holdings Inc
NASDAQ:STRR
|
Revenue
$45.8m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-1%
|
|
DaVita Inc
NYSE:DVA
|
Revenue
$12.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
0%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Revenue
$9.3B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
CVS Health Corp
NYSE:CVS
|
Revenue
$357.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
13%
|
CAGR 10-Years
11%
|
|
Cigna Corp
NYSE:CI
|
Revenue
$195.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
32%
|
CAGR 10-Years
20%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Revenue
$12.3B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
8%
|
Star Equity Holdings Inc
Revenue Breakdown
Breakdown by Geography
Star Equity Holdings Inc
Breakdown by Segments
Star Equity Holdings Inc
Total Revenue:
45.8m
USD
|
Product:
45.8m
USD
|
See Also
What is Star Equity Holdings Inc's Revenue?
Revenue
45.8m
USD
Based on the financial report for Dec 31, 2023, Star Equity Holdings Inc's Revenue amounts to 45.8m USD.
What is Star Equity Holdings Inc's Revenue growth rate?
Revenue CAGR 10Y
-1%
Over the last year, the Revenue growth was -59%. The average annual Revenue growth rates for Star Equity Holdings Inc have been -16% over the past three years , -15% over the past five years , and -1% over the past ten years .